C0014429||Activation
C2354171||general control nonderepressible 2 kinase
C0086418||human
C1182791||glomerular endothelial cells
C0860803||high-glucose
C1704259||molecular pathways
C0033684||protein
C0011881||diabetic nephropathy
C0011881||diabetic nephropathy
C0022646||renal
C0014257||endothelium
C0699748||pathogenesis
C0220825||evaluated
C2354171||general control nonderepressible 2 (GCN2) kinase
C0014429||activation
C0002520||amino acid
C1704259||molecular pathways
C0086418||human
C1182791||glomerular endothelial cells
C1182791||glomerular endothelial cells
C1182791||glomerular endothelial cells
C0430400||cultured
C0020456||high -glucose conditions
C2354171||GCN2 kinase
C2247123||activator
C0526839||tryptophanol
C0168458||Glucose transporter 1
C0168458||Glucose transporter 1
C1171362||expression
C0005863||western blotting
C0162772||reactive oxygen species
C0162772||reactive oxygen species
C0016321||fluorogenic probe
C0243102||Activities
C3536868||glyceraldehyde 3-phosphate dehydrogenase
C3536868||glyceraldehyde 3-phosphate dehydrogenase
C0033634||protein kinase C
C0033634||protein kinase C
C0005507||commercial activity assays
C0037688||sorbitol
C1531834||colorimetrically
C0034338||methylglyoxal
C0014441||ELISA
C0671368||O-linked Î²-N-acetyl glucosamine (O-GlcNAc)-modified proteins
C0005863||western blotting
C0860803||High glucose
C0168458||Glucose transporter 1
C1171362||expression
C0162772||reactive oxygen species
C3536868||glyceraldehyde 3-phosphate dehydrogenase
C0071629||polyol
C1704259||pathway
C0037688||sorbitol
C0033634||protein kinase C
C0243102||activity
C0671368||O-GlcNAc-modified proteins
C0019477||hexosamine
C1704259||pathway
C0162574||advanced glycation endproducts'
C0034338||methylglyoxal
C1182791||glomerular endothelial cells
C0526839||tryptophanol
C0860803||high-glucose
C0014429||Activation
C2354171||GCN2 kinase
C1182791||glomerular endothelial cells
C0860803||high-glucose
C1704259||molecular pathways
C1704259||pathways
C0011881||diabetic nephropathy
C0699748||pathogenesis
C2354171||GCN2 kinase
C0031336||pharmaceutical
C0087111||treatment
C0011881||diabetic nephropathy